ZyKT Cream contains Ketoconazole 2% w/w, an antifungal agent effective in the treatment of various superficial fungal infections of the skin. Ketoconazole belongs to the imidazole class of antifungals and works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. ZyKT Cream is indicated for the management of dermatophytosis, candidiasis, pityriasis versicolor, and seborrheic dermatitis. The cream formulation facilitates topical application, allowing targeted delivery to affected areas with minimal systemic absorption. It is generally well tolerated, though mild local irritation, burning sensation, or itching may occur in some patients. Application should be limited to the affected area once or twice daily as prescribed, and treatment duration typically ranges from 2 to 4 weeks depending on the infection type and severity. Patients are advised to avoid contact with eyes and mucous membranes. ZyKT Cream is contraindicated in individuals with known hypersensitivity to ketoconazole or any cream excipients. Proper adherence to the prescribed regimen is essential to prevent recurrence and resistance. Consult a healthcare professional before use, especially in pregnant or breastfeeding women.